(Medical Xpress)—A published study conducted by researchers at West Virginia University has found that doctor and pharmacy shoppers are at a greater risk for drug-related death.
Sep 7, 2012
0
0
A team of researchers from King's College London and Monash University has created a database of information that relates COVID-19 and type II diabetes. The team has created the database for two reasons—the first is that ...
A study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
Dec 7, 2023
0
36
University of Minnesota Medical School and UnitedHealth Group researchers found that metformin was associated with significantly reduced COVID-19 death risks in women in one of the world's largest observational studies of ...
Dec 4, 2020
1
743
A team of researchers with members affiliated with multiple institutions in Australia and China has found evidence that genetic studies of alcohol drinking could be tainted by people under study who misreport their behavior. ...
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...
May 25, 2012
0
0
People with prehypertension have a 55 percent higher risk of experiencing a future stroke than people without prehypertension, report researchers at the University of California, San Diego School of Medicine in a new meta-analysis ...
Sep 28, 2011
0
0
A team of biochemists at the University of Notre Dame has found a possible new way to treat patients infected with Clostridioides difficile, a type of bacteria that causes serious gastrointestinal problems. In their study, ...
In the United States, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who have private insurance is approximately 400 percent higher than comparable costs paid by the government in the ...
Jan 5, 2012
12
0
(HealthDay)— Levodopa (L-dopa) might hold potential for preventing or treating macular degeneration, according to a study published online Oct. 30 in The American Journal of Medicine.
Nov 13, 2015
0
9
